JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A3011 CHIR-99021 (CT99021)
26 Citation

Target: GSK-3

Summary: GSK-3 inhibitor

≥23.27 mg/mL
A4002 IU1
1 Citation

Summary: Usp14 inhibitor

insoluble in H2O; ≥10.9 mg/mL
A1903 E 64d
8 Citation

Summary: Cysteine protease inhibitor

insoluble in H2O; ≥17.12 mg/mL
A4334 Avanafil
1 Citation

Target: Phosphodiesterases (PDEs)

Summary: PDE5 inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL
A1920 Z-DEVD-FMK
38 Citation

Target: Caspases

Summary: Caspase-3 inhibitor

insoluble in H2O; insoluble in EtOH; ≥60 mg/mL
A3284 Cathepsin S inhibitor
1 Citation

Target: Cathepsins

Summary: Blocks MHCII antigen presentation

≥24.25 mg/mL
A3408 Exendin-4
3 Citation

Target: Glucagon-like peptide 1 (GLP-1) receptors

Summary: GLP-1 activator

≥145 mg/mL
B7945 Urolithin A

≥22.8 mg/mL
C4087 Mebendazole

Summary: broad-spectrum anthelmintic that inhibits intestinal microtubule synthesis

insoluble in H2O; insoluble in EtOH; ≥13 mg/mL
A1124 Amyloid Beta-Peptide (1-40) (human)
1 Citation

Summary: residues 1-40 of human amyloid-beta

insoluble in EtOH; ≥23.8 mg/mL